Patent · US Active

Anti-BCMA antibodies

US9034324B2 · kind B2 · utility

70Cited by
9References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 10, 2010
Grant dateMay 19, 2015
Priority date—
Expiry dateJan 16, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/732
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention provides antibodies that recognize the B Cell Maturation Antigen (BCMA) and that bind naïve B cells, plasma cells, and/or memory B cells. The invention further provides methods for depleting naïve B cells, plasma cells, and memory B cells, and for treating B cell-related disorders, including lymphomas and autoimmune diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.